Chemistry & Biochemistry’s Dr. Xiaohua Peng was featured in In Focus discussing her new start-up SynXT Therapeutics. SynXT Therapeutics (founded by Dr. Peng and former UWM graduate student Dr. Taufeeque Ali) are developing a new type of cancer therapy. This therapy has shown promise in treating triple negative breast cancer without the side effects of traditional chemotherapy. You can read more about Drs. Peng and Ali’s journey with SynXT Therapeutics and breast cancer research in In Focus.